SYH2059 Tablets
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
InnovStone Therapeutics Limited
Overview
SYH2059 Tablets is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
SYH2059 Tablets clinical trials
Explore related
Medical disclaimer. This page summarizes research about SYH2059 Tablets for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.